The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies
ValiRx plc is listed on AIM of the London Stock Exchange under the ticker code VAL. There are no restrictions on the transfer of ValiRx’s shares and these are not listed on any other exchange.
These disclosures were last reviewed on the 25-08-2023.
ValiRx plc is a company incorporated in the United Kingdom under the Companies Act 1985, it's “principal” place of business is in the United Kingdom.
UK City Code on Takeovers and Mergers:- Valirx is subject to the UK City Code on Takeovers and Mergers.
The Total Number of AIM Securities in issue with nominal value of 0.1p is 102,319,610
The information below was last updated on 6 February 2023.
The percentage of AIM Securities not in public hands is approximately 23%.
Shareholder(s) with more than 3%
Shareholders | Number of Shares | Percentage of Total |
---|---|---|
Mr Adam Hargreaves | 7,749,163 | 7.57% |
Monecor (London) Ltd | 4,466,969 | 4.37% |
Shareholders | Number of Shares | Percentage of Total |
---|---|---|
Directors (combined) | 1,061,669 | 1.0% |
Kevin Cox | 372,333 | 0.36% |
Gerry Desler | 128,668 | 0.13% |
Suzanne Dilly | 416,668 | 0.41% |
Martin Lampshire | 144,000 | 0.14% |
Cavendish Securities plc. One Bartholomew Close, London, EC1A 7BL Email: info@cavendish.com
Tel: +44 (0) 20 7397 8900
www.cavendish.com
Turner Pope Investments (TPI) Limited.
6-8 Frederick's Place, London, EC2R 8AB
Email: info@turnerpope.com
Tel: +44 (0) 20 3657 0050
www.turnerpope.com
Cairn Financial Advisers LLP, Ninth Floor, 107 Cheapside, London, EC2V 6DN
www.cairnfin.com
Neville Registrars Limited, Neville House, Steelpark Road, Halesowen B62 8HD
Email: info@nevilleregistrars.co.uk
Tel: +44 (0) 121585 1131
www.nevilleregistrars.co.uk
DACBeachcroft, 25 Walbrook, London, EC4N 8AF
www.dacbeachcroft.com/en/gb/locations/london-walbrook
Adler Shine, Aston House, Cornwall Avenue, Finchley, N3 1LF
The Co-operative Bank, PO Box 250, Delph House, Southway, Skelmersdale, WN8 6WT.
The Board of Directors is committed to applying high standards of corporate governance using the guidance of the QCA Code, revised in April 2018 as devised by the Quoted Companies Alliance.
The Corporate Governance sets out ValiRx’s compliance with the ten principles of the QCA Code, displaying how the company complies, and provides links to appropriate disclosures.
These arrangements are also disclosed in our Annual Report and Accounts.
These disclosures were last reviewed on the 25-08-2023.